Related Experiment Video

Updated: Jun 26, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma

Ken Takahashi1, Masao Miyashita, Hiroshi Makino

  • 1Graduate School of Medicine, Department of Surgery, Surgery for Organ Function and Biological Regulation, Nippon Medical School, Bunkyo-ku, Tokyo, Japan. kentaka-nms@nms.ac.jp

Experimental and Molecular Pathology
|January 7, 2009
PubMed

Insights

The Akt-Mdm2 pathway is crucial in esophageal squamous cell carcinoma (ESCC) development. Akt protein levels regulate Mdm2 expression, impacting tumor growth and potentially offering new therapeutic targets for ESCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The Akt-Mdm2 signaling pathway is implicated in various cancers.
  • Its specific role in esophageal squamous cell carcinoma (ESCC) remains underexplored.
  • Understanding this pathway is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate Akt and Mdm2 protein and mRNA expression in ESCC tissues.
  • To elucidate the functional relationship between Akt and Mdm2 in ESCC.
  • To explore the potential of targeting the Akt-Mdm2 pathway for ESCC treatment.

Main Methods:

  • Analysis of Akt1-3 and Mdm2 protein and mRNA expression in 23 ESCC patient samples.
  • Utilizing siRNA to knock down Akt isoforms in ESCC cell lines.
  • Assessing the impact of Akt knockdown on Mdm2 protein levels.

Main Results:

  • Akt1 and Mdm2 proteins were detected in 77.8% and 66.7% of ESCC tumors, respectively.
  • Both Akt1 and Mdm2 mRNA levels were significantly elevated in tumor tissues compared to normal tissues.
  • Knockdown of Akt isoforms led to a reduction in Mdm2 protein expression.

Conclusions:

  • Overexpression of Akt1 and Mdm2 is associated with esophageal carcinogenesis.
  • Akt signaling directly regulates Mdm2 expression in ESCC.
  • This regulatory axis may influence wild-type p53 function, presenting potential therapeutic targets for esophageal cancer.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...